Pyrroles
- (1)
- (84)
- (1)
- (6)
- (1)
- (5)
- (2)
- (6)
- (1)
- (13)
- (1)
- (3)
- (1)
- (14)
- (46)
- (3)
- (1)
- (1)
- (1)
- (6)
- (2)
- (1)
- (1)
- (2)
- (2)
- (1)
- (1)
- (1)
- (1)
- (3)
- (1)
- (4)
- (1)
- (1)
- (2)
- (1)
- (7)
- (1)
- (1)
- (7)
- (2)
- (1)
- (1)
- (1)
- (5)
- (3)
- (1)
- (3)
- (1)
- (1)
- (1)
- (1)
- (9)
- (1)
- (2)
- (1)
- (1)
- (1)
- (1)
- (3)
- (4)
- (1)
- (2)
- (1)
- (1)
- (2)
- (3)
- (1)
- (1)
- (2)
- (1)
- (2)
- (1)
- (1)
- (1)
- (1)
- (1)
- (3)
- (3)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (3)
- (2)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (2)
- (2)
- (2)
- (1)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (1)
- (2)
- (1)
- (1)
- (1)
- (1)
- (1)
- (2)
- (2)
- (2)
- (2)
- (2)
- (4)
- (1)
- (2)
- (1)
- (4)
- (1)
- (7)
- (1)
- (12)
- (4)
- (6)
- (1)
- (2)
- (1)
- (4)
- (10)
- (4)
- (58)
- (17)
- (10)
- (2)
- (1)
- (36)
- (1)
- (2)
- (9)
- (2)
- (2)
- (1)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (1)
- (3)
- (1)
- (1)
- (2)
- (1)
- (1)
Filtered Search Results
Medchemexpress LLC (-)-Corey lactone diol | 32233-40-2 | 172.18 | 10 G
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
(-)-Corey lactone diol is the reduced form of Corey aldehyde, serving as a versatile drug intermediate. It is commonly used in the synthesis of compounds such as Beraprost.
- Reduced form of Corey aldehyde
- Used as a drug intermediate for synthesis
- Appears as a solid
- Purity 98.0%
- White to off-white appearance
- Stable under recommended storage conditions
- For research use only
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC 4-(4,5-diphenyl-1H-imidazol-2-yl)benzoyl chloride | 162756-62-9 | 98.0% | 358.82 | C22H15ClN2O | 10 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
4-(4,5-diphenyl-1H-imidazol-2-yl)benzoyl chloride is a benzoyl chloride derivative used as a labeling reagent for amines and for HPLC derivatization in analytical and research workflows. Supplied as a solid with high purity suitable for laboratory use.
- Used to derivatize amines for HPLC analysis
- Fluorescent imidazolyl moiety aids sensitive detection
- High purity (98.0%) suitable for analytical work
- Available in small, controlled package sizes for research use
- Stable solid form for convenient storage and handling
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC N-Desethyl Sunitinib | 356068-97-8 | 99.9% | 370.42 | 1 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
N-Desethyl Sunitinib (SU-12662) is a metabolite of Sunitinib. It serves as a transport substrate for human ABCB1, ABCG2, and murine ABCG2.
- Metabolite of Sunitinib.
- Serves as a good transport substrate for human ABCB1, ABCG2 and murine ABCG2.
- For research use only.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC RIPK1-IN-4 | 1481641-08-0 | 98.9% | 401.46 | C23H23N5O2 | 10 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
A potent, selective type II kinase inhibitor of receptor-interacting protein 1 (RIP1) that binds the DLG-out inactive conformation. It exhibits low-nanomolar biochemical potency (RIP1 IC50 16 nM; ADP-Glo IC50 10 nM) and shows cellular activity against RIP1-mediated necroptosis, making it suitable as a research tool for studies of RIP1 signaling and necroptosis.
- Potent biochemical inhibition of RIP1 (IC50 16 nM).
- Low-nanomolar ADP-Glo kinase activity (IC50 10 nM).
- Cellular efficacy in necroptosis models (L929, U-937).
- High purity and white to off-white solid appearance.
- High DMSO solubility (250 mg/mL) with ultrasonic assistance.
- Stable when stored per recommended conditions (powder and solvent).
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC Atorvastatin epoxy tetrahydrofuran impurity | 873950-19-7 | 449.47 | 50 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Atorvastatin epoxy tetrahydrofuran impurity is an impurity isolated from the oxidative degradation products of atorvastatin. Atorvastatin is an orally active HMG-CoA reductase inhibitor that effectively decreases blood lipids. This product is for research use only and not sold to patients.
- Isolated from oxidative degradation products of atorvastatin.
- Atorvastatin is an orally active HMG-CoA reductase inhibitor.
- Effectively decreases blood lipids.
- Reduces apoptosis of myocardial cells by down-regulating GRP78, caspase-12, and CHOP expression after myocardial infarction.
- Involved in activation of endoplasmic reticulum (ER) stress in response to heart failure and angiotensin II (Ang II) stimulation.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC Jnj-18038683 | 851376-05-1 | 99.8% | 529.97 g/mol | C26H28ClN3O7 | 10 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
This small-molecule research compound is a selective antagonist of the 5-hydroxytryptamine type 7 (5-HT7) receptor used in pharmacology and neuroscience studies. It shows high affinity in binding assays (pKi ≈ 8.19-8.20 for rat and human 5-HT7 in HEK293 cells), produces concentration-dependent inhibition of 5-HT-stimulated adenylyl cyclase, and alters REM sleep in rodent models. Supplied as a solid or as a DMSO solution for in vitro and in vivo research.
- Selective 5-HT7 receptor antagonist with high binding affinity.
- Demonstrated functional antagonism in adenylyl cyclase assays.
- Modulates REM sleep parameters in rodent studies.
- High purity suitable for research applications.
- Available as solid and ready-to-use DMSO solution.
- Store sealed and protect from moisture; follow supplier storage guidelines.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC JNJ-42226314 50 mg
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
JNJ-42226314 50MG
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC STING agonist-3 trihydrochloride | 98.4% | 860.19 g/mol | C37H45Cl3N12O6 | 1 ML
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
STING agonist-3 trihydrochloride is a selective, non-nucleotide small-molecule stimulator of interferon genes (STING) supplied as a 10 mM solution in DMSO for research use. The compound is provided as the trihydrochloride salt with reported purity of 98.36% and molecular weight 860.19 g/mol; storage recommendations are solid at 4°C protected from light and under nitrogen, and in solvent at -80°C (up to 6 months) or -20°C (up to 1 month).
- Selective non-nucleotide STING agonist with pEC50 of 7.5.
- Supplied as a 10 mM solution in DMSO, 1 mL vial.
- Trihydrochloride salt form to aid handling and solubility.
- High purity (98.36%) with supporting analytical data.
- Intended for immuno-oncology and STING pathway research.
- Documentation available: datasheet, COA, SDS, HNMR, LCMS.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC Nemonoxacin malate | 951163-60-3 | 99.3% | 505.52 | 25 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Nemonoxacin malate | 951163-60-3 | 99.3% | 505.52 | 25 MG
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC ATORVASTATIN ETHYL E 100 mg
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
ATORVASTATIN ETHYL E 100MG
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC ATORVASTATIN METHYL 100 mg
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
ATORVASTATIN METHYL 100MG
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC TLR7/8 agonist 3 | 642473-95-8 | 100.0% | 50 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
A potent agonist for TLR7 and TLR8, this compound is derived from patent WO2016057618 (compound of formula (II)) and is intended for research use only. It induces IFN-α and TNF-α in PBMC with EC50 values of 0.12 μM and 0.37 μM, respectively.
- Potent agonist for TLR7 and TLR8.
- Induces IFN-α and TNF-α.
- Suitable for in vitro research applications.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC TLR7/8-IN-1 | 2205095-75-4 | MFCD34567724 | 99.9% | C29H40N8O2 | 10MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
TLR7/8-IN-1 is a crystalline small-molecule inhibitor of Toll-like receptors 7 and 8, described in patent WO2019220390 (compound 2b). It is supplied as a high-purity research reagent for studies of TLR-mediated signaling and autoimmune disease.
- High purity (99.9%).
- White to off-white solid appearance.
- Molecular formula C29H40N8O2; molecular weight 532.68 g·mol⁻¹.
- Available in multiple pack sizes and solution formats (10 mM in DMSO).
- Intended for research use in TLR7/TLR8 biology and autoimmune disease models.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC TLR7/8 agonist 3 | 642473-95-8 | 100.0% | C17H23N5O | 10MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
TLR7/8 agonist 3 is a small-molecule agonist of Toll-like receptors 7 and 8 used for immunology research. Described in patent literature, it is supplied in high purity as a solid and is also available as a DMSO solution for in vitro and in vivo studies. Supplier documents include solubility, formulation, and storage guidance for research applications.
- Potent TLR7 and TLR8 agonist activity
- High purity suitable for research applications
- Available as solid and DMSO solution for flexible dosing
- Documented solubility and in vivo formulation guidance
- Stable long-term storage recommendations for powder form
- Characterized chemical formula and molecular weight
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC Tlr7/8/9-in-1 | 2180127-82-4 | 98.5% | C27H37N3O2 | 10MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
TLR7/8/9-IN-1 is a potent, orally bioavailable small-molecule antagonist of Toll-like receptors 7, 8, and 9 intended for research use in immunology and inflammation studies. It inhibits TLR-mediated signaling in cellular assays and demonstrates low-nanomolar antagonist activity in PBMCs, supporting mechanistic and preclinical investigations.
- Potent antagonist with IC50 = 43 nM against TLR7/8/9.
- Low-nanomolar activity in PBMCs (TLR7 IC50 = 4.8 nM; TLR9 IC50 = 510 nM).
- Orally bioavailable small molecule suitable for in vivo and in vitro studies.
- High purity (98.51%) appropriate for biochemical assays.
- Available as solid and as 10 mM in DMSO solutions for flexible dosing.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More